Loading
Latest filing published 27 Feb 2026 for Volitionrx Ltd.
Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jacob Vincent Micallef appears in our data through filings on Volitionrx Ltd shares, published by SEC (Form 4). Between 9 December 2015 and 26 February 2026, the trades on record add up to 31 filings.
No open-market sale appears; the market trades are 7 purchases worth €186k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 19 share grants and 5 option exercises.
The median purchase comes to €22k. 7 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster. Ninety days after publication, 7 purchases show a median change of -32.9%, with the price up in 29% of them. This is a record of the past, not a forecast.
On 27 February 2026 came the latest disclosure, a share grant in Volitionrx Ltd. The latest purchase dates back some time: it was published 1,150 days ago, on 31 August 2023. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations